Surgical Results of Ahmed Glaucoma Valve Implantation in One-chamber Eyes
Related Experiment Video
Updated: Nov 6, 2025

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Masaki Tanito1, Aika Tsutsui1, Kaoru Manabe2
1Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo.
Insights
Ahmed glaucoma valve (AGV) implantation effectively reduced intraocular pressure (IOP) and medication use in eyes with damaged iris-lens diaphragms. This surgical approach is a viable option for managing complex glaucoma cases.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Ocular Implants
Background:
- Glaucoma in eyes with damaged iris-lens diaphragms presents unique surgical challenges.
- Controlling intraocular pressure (IOP) is crucial for preventing further vision loss in these patients.
Purpose of the Study:
- To evaluate the efficacy and safety of Ahmed glaucoma valve (AGV) implantation with pars plana tube insertion for IOP control in glaucomatous eyes with damaged iris-lens diaphragms ('1-chamber' eyes).
Main Methods:
- Retrospective review of 52 glaucomatous '1-chamber' eyes (mean age 76.0 years) undergoing AGV implantation with pars plana tube insertion.
- Data collected included preoperative and postoperative IOP, medication use, visual acuity, and complications.
Main Results:
- Mean IOP decreased by 66% and antiglaucoma medications by 59% (P<0.0001) at a mean 23-month follow-up.
- Success rates for IOP control were 82.5% at year 1 and 79.0% at year 2.
- Common complications included macular edema (17%), choroidal detachment (15%), and vitreous hemorrhage (13%).
Conclusions:
- Pars plana AGV tube insertion with simultaneous vitrectomy is a reasonable surgical choice for IOP reduction in glaucomatous eyes with damaged iris-lens diaphragms.
- This technique helps minimize vision-threatening complications while effectively managing IOP.
Precis:
Ahmed glaucoma valve (AGV) implantation in eyes with damaged iris-lens diaphragms ("1-chamber" eyes) resulted in mean intraocular pressure (IOP) and antiglaucoma medications decreases of 66% and 59% (P<0.0001 for both), respectively, at the mean 23-month follow-up.
Purpose:
The purpose of this study was to report the results of AGV implantation with pars plana tube insertion to control IOP in glaucomatous eyes with damaged iris-lens diaphragms ("1-chamber" eyes).
Methods:
The medical records of 52 consecutive glaucomatous 1-chamber eyes (48 Japanese patients, mean age±SD, 76.0±11.2 y) were retrospectively reviewed. Other than aphakic eyes, eyes were defined as having 1 chamber if intraocular lenses (IOLs) were sclerally or intrasclerally fixated, IOLs were fixed on-the-bag due to posterior capsular defects, vitreous collapse into the anterior chamber resulted from Zinn zonular dialysis, and phacodonesis or IOL-donesis required lens/IOL explantation during AGV implantation. The data collected were preoperative/postoperative IOPs, numbers of antiglaucoma medications, visual acuity, anterior chamber flare, visual field mean deviation, corneal endothelial cell density, and surgical complications/interventions.
Results:
The preoperative IOP (28.5±9.4 mm Hg) and a number of antiglaucoma medications (3.2±1.2) decreased significantly (P<0.0001 for both) to 9.8±3.3 mm Hg and 1.3±1.3, respectively, at the final visit (mean follow-up, 23 mo). The success rates of IOP control (6 to 21 mm Hg and >20% reduction irrespective of medication use) were 82.5% and 79.0%, respectively, at postoperative years 1 and 2. The most common postoperative complications were macular edema (n=9, 17%), choroidal detachment (n=8, 15%), vitreous hemorrhage (n=7, 13%), and hyphema (n=7, 13%). The most common postoperative intervention was tubal repositioning/reopening (n=6, 12%). Compared with preoperative values, the visual acuity, anterior chamber flare, mean deviation, corneal endothelial cell density remained unchanged postoperatively.
Conclusion:
Choice of pars plana AGV tube insertion with simultaneous vitrectomy is reasonable to achieve IOP reduction and minimize vision-threatening complication in glaucomatous eyes with a damaged iris-lens diaphragm.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview

